Adjuvant therapy has been shown to improve recurrence-free survival after complete resection of Stage III and Stage IV melanoma, and there are a number of PBS-subsidised adjuvant therapies available in Australia. Unfortunately, despite receiving adjuvant treatment, around 50% of patients still recur. In this podcast, medical oncologist at Chris O’Brien Lifehouse Jenny Lee talks to ...
Treatment options for melanoma patients progressing post-adjuvant therapy
15 Feb 2021
Sponsored by Bristol Myers Squibb Australia Pty Ltd